Insider · CIK 0001555794

Xie Lan

Reports to the SEC for 1 company · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001555794

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-10-13	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+8,000 sh	—	—	8,000
2017-10-13	SCICLONE PHARMACEUTICALS INCD Disposition to Issuer	VP Finance, China CFO	DDisposition to Issuer	−8,000 sh	$11.18	−$89.4K	0
2017-10-13	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer	VP Finance, China CFO	DDisposition to Issuer	−2,500 sh	$6.65	−$16.6K	0
2017-10-13	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer	VP Finance, China CFO	DDisposition to Issuer	−16.7K sh	$6.66	−$111K	0
2017-10-13	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer	VP Finance, China CFO	DDisposition to Issuer	−18.7K sh	$2.35	−$43.9K	0
2017-10-13	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−2,000 sh	—	—	0
2017-10-13	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer	VP Finance, China CFO	DDisposition to Issuer	−28K sh	$2.06	−$57.7K	0
2017-10-13	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−3,000 sh	—	—	0
2017-10-13	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−3,000 sh	—	—	0
2017-10-13	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer	VP Finance, China CFO	DDisposition to Issuer	−21K sh	$1.53	−$32.1K	0
2017-08-16	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−10K sh	$11.00	−$110K	0
2017-08-15	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+10K sh	—	—	10,000
2017-08-15	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−10K sh	—	—	8,000
2017-06-12	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+1,000 sh	—	—	1,000
2017-06-12	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−1,000 sh	$10.75	−$10.8K	0
2017-06-12	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−1,000 sh	—	—	18,000
2017-03-16	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−1,000 sh	$9.60	−$9,600	0
2017-03-15	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+1,000 sh	—	—	1,000
2017-03-15	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−1,000 sh	—	—	19,000
2017-03-08	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitA Award	VP Finance, China CFO	AAward	+3,000 sh	—	—	20,000
2017-03-08	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	VP Finance, China CFO	AAward	+21K sh	—	—	21,000
2016-08-12	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+9,333 sh	$8.83	+$82.4K	9,333
2016-08-12	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−9,333 sh	$10.36	−$96.7K	0
2016-08-12	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+7,500 sh	$4.52	+$33.9K	7,500
2016-08-12	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−7,500 sh	$10.36	−$77.7K	0
2016-08-12	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+2,812 sh	$4.53	+$12.7K	2,812
2016-08-12	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−2,812 sh	$10.36	−$29.1K	0
2016-08-12	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+12.2K sh	$5.19	+$63.3K	12,187
2016-08-12	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−12.2K sh	$10.36	−$126K	0
2016-08-12	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+1,000 sh	—	—	1,000
2016-08-12	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−1,000 sh	$10.41	−$10.4K	0
2016-08-12	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Options (right to buy)M Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−7,500 sh	—	—	16,667
2016-08-12	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Options (right to buy)M Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−2,812 sh	—	—	2,500
2016-08-12	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Options (right to buy)M Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−12.2K sh	—	—	0
2016-08-12	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Options (right to buy)M Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−9,333 sh	—	—	18,667
2016-08-12	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitA Award	VP Finance, China CFO	AAward	+10K sh	—	—	18,000
2016-08-12	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−1,000 sh	—	—	17,000
2016-03-15	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	VP Finance, China CFO	AAward	+28K sh	—	—	28,000
2016-03-15	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitA Award	VP Finance, China CFO	AAward	+4,000 sh	—	—	8,000
2015-12-03	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+4,166 sh	$4.52	+$18.8K	4,166
2015-12-03	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−4,166 sh	$9.50	−$39.6K	0
2015-12-03	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+1,875 sh	$4.53	+$8,493.75	1,875
2015-12-03	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−1,875 sh	$9.50	−$17.8K	0
2015-12-03	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+8,125 sh	$5.19	+$42.2K	8,125
2015-12-03	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−8,125 sh	$9.50	−$77.2K	0
2015-12-03	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−4,166 sh	—	—	24,167
2015-12-03	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−1,875 sh	—	—	5,312
2015-12-03	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	−8,125 sh	—	—	12,187
2015-05-15	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	VP Finance, China CFO	MExercise/Conversion	+12.2K sh	$5.19	+$63.3K	12,188
2015-05-15	SCICLONE PHARMACEUTICALS INCS Sale	VP Finance, China CFO	SSale	−12.2K sh	$9.20	−$112K	0

Recent filings

Accepted (ET)
Oct 164
Xie Lan0000899243-17-024251
SEC(opens sec.gov)
Aug 164
Xie Lan0000880771-17-000128
SEC(opens sec.gov)
Jun 144
SCICLONE PHARMACEUTICALS INC0000880771-17-000108
SEC(opens sec.gov)
Mar 174
SCICLONE PHARMACEUTICALS INC0000880771-17-000056
SEC(opens sec.gov)
Mar 94
SCICLONE PHARMACEUTICALS INC0000880771-17-000041
SEC(opens sec.gov)

Companies

SCICLONE PHARMACEUTICALS INCVP Finance, China CFO

Address

950 TOWER LANE, SUITE 900

FOSTER CITY, CA, 94404